招聘
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com.
As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world. We provide an inclusive work environment where each person is considered as an individual. At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.
Job Function:
Data Analytics & Computational SciencesJob Sub Function:
Data ScienceJob Category:
Scientific/TechnologyAll Job Posting Locations:
Cornellà de Llobregat, Barcelona, Spain, Madrid, SpainJob Description:
Johnson & Johnson Innovative Medicine is seeking a Senior Scientist to join the Data Science & Digital Health (DSDH) organization, based in Spain. In this role, you will lead the design, execution, and application of advanced computational models to integrate multi‑modal perturbation data and human omics datasets for target/pathway nomination.
Key Responsibilities
You will drive the development of predictive frameworks for disease state reversal, nominate synergistic target combinations, and perform in silico target deconvolution to inform portfolio decisions in immune‑mediated diseases.
In this role, you will:
Lead the design, optimization, and validation of human‑omics driven perturbation prediction models integrating CRISPR KO, transcriptomics, proteomics, cytokine profiles, and other cellular screening data to predict disease‑reversal phenotypes in disease models.
Develop advanced computational strategies to perform target deconvolution, identify target combinations and pathway perturbation that most effectively reverse pathogenic activity.
Build human‑omics based phenotype scoring frameworks to quantify perturbation efficacy, validated across internal datasets and public databases.
Collaborate closely with therapeutic discovery, disease biology and preclinical safety leads to translate in vitro perturbation outcomes into relevant human disease biology insights, and to translate computational outputs into experimental validation strategies.
Provide technical leadership — set analytical roadmaps, define milestones, quantify success metrics, and ensure reproducibility and scalability across workflows.
Qualifications
Required:
Ph.D. in Bioinformatics, Computational Biology, Data Science, Biomedical Engineering, Computer Science, Artificial Intelligence, or a related field.
2+ years postdoctoral or industry experience in large‑scale multi‑omics data analysis (e.g., genomics, transcriptomics, proteomics), preferably in therapeutic discovery or translational research.
Proven expertise in AI/ML modeling for biological datasets, prediction modeling, phenotype scoring, and multi‑omics integration.
Experience with systems biology/network analysis
Advanced skills in high‑performance/cloud computing, reproducible pipeline development, and workflow optimization.
Excellent written and oral communication skills for multidisciplinary teams. Demonstrated record of impactful research (peer‑reviewed publications, conference talks).
Preferred:
Experience in in vitro perturbation data analysis and chemical‑target mapping.
Knowledge of public omics databases.
Background in network/pathway analysis and integrative data harmonization across platforms.
Familiarity with immune‑mediated disease biology, especially fibroblast pathobiology.
Impact of the Role
In this role, you will be at the forefront of J&J’s initiatives to unlock novel therapeutic strategies by integrating proprietary perturbation datasets with cutting‑edge computational modeling. Your work will directly advance therapeutic discovery and translational research. You will have the flexibility to work at our Spanish sites or remotely, with global team integration.
Required Skills:
Preferred Skills:
Advanced Analytics, Business Intelligence (BI), Coaching, Collaborating, Critical Thinking, Data Analysis, Database Management, Data Privacy Standards, Data Reporting, Data Savvy, Data Science, Data Visualization, Econometric Models, Process Improvements, Technical Credibility, Technologically Savvy, Workflow AnalysisTotal Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Staff Research Scientist - Music
Spotify · New York, NY

Sr. Growth Data Scientist
DocuSign · Sao Paulo, Brazil

Senior Data Scientist, Growth Product
Block (Square) · Bay Area, CA, United States of America

Senior Data Scientist
Empower · KA Bangalore

Sr Advanced Data Scientist
Honeywell · Bengaluru, Karnataka, India, IN
About Johnson & Johnson

Johnson & Johnson
PublicCaring for the world, one person at a time.
10000+
Employees
New Brunswick
Headquarters
Reviews
3.6
5 reviews
Work Life Balance
3.8
Compensation
2.5
Culture
3.0
Career
3.2
Management
2.8
45%
Recommend to a Friend
Pros
Good work-life balance
Strong R&D division
University talent engagement
Cons
Contract employee job security issues
Pay cuts during transitions
Product liability concerns
Salary Ranges
2,248 data points
Junior/L3
L3
L5
L6
Mid/L4
Senior/L5
Staff/L6
Junior/L3 · Data Scientist Level 23
0 reports
$105,109
total / year
Base
-
Stock
-
Bonus
-
$89,343
$120,875
Interview Experience
7 interviews
Difficulty
3.0
/ 5
Duration
14-28 weeks
Experience
Positive 0%
Neutral 86%
Negative 14%
Interview Process
1
Application Review
2
HireVue Video Interview
3
Recruiter Screen
4
Technical/Hiring Manager Interview
5
Panel Interview
6
Offer
Common Questions
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Case Study
News & Buzz
Is Johnson & Johnson (JNJ) The Most Profitable Healthcare Stock To Buy? - Finviz
Source: Finviz
News
·
5w ago
Is Johnson & Johnson (JNJ) The Most Profitable Healthcare Stock To Buy? - Insider Monkey
Source: Insider Monkey
News
·
5w ago
Johnson & Johnson Weighs Oncology Progress Against Easing Talc Legal Risks - simplywall.st
Source: simplywall.st
News
·
5w ago
New York State Common Retirement Fund Decreases Stock Position in Johnson & Johnson $JNJ - MarketBeat
Source: MarketBeat
News
·
5w ago